Payment for services is made exclusively to the company's account. For your convenience, we have launched Kaspi RED 😎

Home / Convention / Resolution / Concept / On the Concept for the Development of the Common Market for Medical Devices within the Eurasian Economic Union

On the Concept for the Development of the Common Market for Medical Devices within the Eurasian Economic Union

АMANAT партиясы және Заң және Құқық адвокаттық кеңсесінің серіктестігі аясында елге тегін заң көмегі көрсетілді

On the Concept for the Development of the Common Market for Medical Devices within the Eurasian Economic Union

Order No. 10 of the Eurasian Intergovernmental Council dated August 15, 2025.

For the purpose of implementing paragraph 4.10.1 of the Strategic Directions for the Development of Eurasian Economic Integration until 2025, approved by Decision No. 12 of the Supreme Eurasian Economic Council dated December 11, 2020:

  1. To approve the Concept for the Development of the Common Market for Medical Devices within the Eurasian Economic Union.

    The Eurasian Economic Commission shall publish the said Concept on the official website of the Eurasian Economic Union.

  2. The governments of the Member States of the Eurasian Economic Union and the authorized bodies in the field of medical device circulation of the Member States of the Eurasian Economic Union shall be guided by the Concept for the Development of the Common Market for Medical Devices within the Eurasian Economic Union for the purpose of developing the common market for medical devices.
  3. This Order shall enter into force on the date of its publication on the official website of the Eurasian Economic Union.

Members of the Eurasian Intergovernmental Council:

On behalf of the Republic of ArmeniaOn behalf of the Republic of BelarusOn behalf of the Republic of KazakhstanOn behalf of the Kyrgyz RepublicOn behalf of the Russian Federation
 APPROVED by Order No. 10 of the Eurasian Intergovernmental Council dated August 15, 2025

CONCEPT for the Development of the Common Market for Medical Devices within the Eurasian Economic Union

I. INTRODUCTION

This Concept for the Development of the Common Market for Medical Devices within the Eurasian Economic Union (hereinafter referred to respectively as the Concept, the common market for medical devices, and the Union) has been developed for the purpose of implementing paragraph 4.10.1 of the Action Plan for the Implementation of the Strategic Directions for the Development of Eurasian Economic Integration until 2025, approved by Order No. 4 of the Council of the Eurasian Economic Commission dated April 5, 2021.

The strategic goal and objectives of this Concept are set out in Section III.

II. CURRENT STATE OF THE MEDICAL DEVICE MARKET WITHIN THE UNION

1. Industry volume and dynamics¹

 

¹ Based on the materials of the report “The Market for Medical Devices and Products Used in the Provision of Medical Care in the EAEU (2018–2021)”, prepared by the Eurasian Economic Commission.

An analysis of the foreign trade activities of the Member States of the Union in relation to medical devices for the period 2018–2021 was used to assess the industry. Changes that occurred as a result of the introduction of economic pressure measures against a number of Member States in 2022–2023 are not considered in this subsection of the Concept due to restrictions on access to statistical information.

In total, 20 commodity groups of medical products classified under 4-digit HS codes were examined in the analysis.

At the end of 2021, the foreign trade turnover of the Member States of the Union in medical products exceeded USD 10.2 billion, surpassing the 2020 figures by 4.4%, while the base increase compared to 2018 amounted to 21.8%. At the same time, the average annual growth rate stood at 6.8%. Since 2018, the value of trade turnover has increased by USD 1.8 billion.

The major part of this amount, up to 87.6%, accounted for import operations and amounted to USD 9.0 billion. Throughout the period from 2018 to 2021, an increase in the volume of medical products supplied to the Member States of the Union was observed. In 2021, growth of 3.3% compared to 2020 was recorded, while the base growth compared to 2018 reached 26.3%, bringing the average annual growth rate to 8.1%. Thus, in value terms, imports increased by almost USD 1.8 billion during the period under consideration, while their share in trade turnover increased from 84.5% to 87.6%.

With regard to export operations involving medical products, fluctuating dynamics were observed during the period 2018–2021. Thus, in 2019 and 2021, the indicators increased by 5.1% and 12.8%, respectively, compared to the previous year. However, the base indicator for 2021 compared to 2018 amounted to -2.6%. In value terms, the volume of export operations at the end of the period under consideration decreased by more than USD 0.03 billion, falling from USD 1.3 billion in 2018 to USD 1.27 billion in 2020. These fluctuations resulted in average annual indicators of -0.9%. At the end of 2021, the share of export operations in the trade turnover of the Member States of the Union decreased to 12.4%, whereas in 2018 this indicator stood at 15.5%.

During the period under consideration, a clear decline in the trade balance of the Member States of the Union was observed. Whereas in 2018 the negative trade balance of the Member States of the Union amounted to USD -5.8 billion, by the end of 2021 this indicator had increased to USD -7.8 billion. This trend indicates the growing dependence of the Member States of the Union on imports of medical products, while third-country markets are not increasing their purchases of medical products manufactured in the territories of the Member States of the Union.

At the end of 2021, the main commodity groups occupying leading positions in the import operations of the Member States of the Union were as follows:

  1. HS Code 9018 – instruments and appliances used in medical, surgical, dental or veterinary sciences, including scintigraphic apparatus, other electromedical apparatus and sight-testing instruments. During the period 2018–2021, an increase in import operations for this commodity group was observed. The base growth indicator compared to 2018 reached 34.7% at the end of the period, while the average annual indicator stood at 10.4%. At the end of 2021, the share of these goods in the import structure amounted to 33.6%, which in value terms amounted to USD 3.0 billion.

The Russian Federation was the main importer of goods in this group among the Member States of the Union in 2021, having purchased approximately 86.9% of all imported products, amounting to USD 2.5 billion. The Republic of Kazakhstan imported these products in the amount of USD 284.4 million (9.4%), the Republic of Belarus – USD 173.4 million (5.7%), the Republic of Armenia – USD 38.7 million (1.3%), and the Kyrgyz Republic – USD 18.3 million (0.6%).

The main suppliers of goods in the commodity group under consideration to the Member States of the Union in 2021 were Germany, which supplied products worth USD 637.0 million, or 21.0% of the total volume, followed by China – USD 512.7 million (16.9%), the United States – USD 416.6 million (13.7%), Japan – USD 350.0 million (11.6%), and Korea – USD 170.3 million (5.6%).

  1. HS Code 9021 – orthopedic appliances, including crutches, surgical belts and trusses; splints and other appliances for the treatment of fractures; artificial parts of the body; hearing aids and other appliances which are worn or carried, or implanted in the body, to compensate for a defect or disability (9.3% / USD 0.9 billion).

The Russian Federation was the main importer of products in this commodity group in 2021, having purchased more than 82.2% of all goods in this category imported into the customs territory of the Union, amounting to more than USD 773.4 million. Among the other Member States of the Union, a significant volume of supplies went to the Republic of Kazakhstan, whose share amounted to 10.1%, equivalent to USD 95.2 million in value terms. Goods worth USD 50.9 million (5.4%) were supplied to the Republic of Belarus, USD 17.5 million (1.97%) to the Republic of Armenia, and USD 3.9 million to the Kyrgyz Republic, equivalent to a share of 0.4%.

The main suppliers of goods in the commodity group under consideration to the Member States of the Union in 2021 were the United States, which supplied products worth USD 186.7 million, or 19.8% of the total volume, followed by Germany – USD 113.6 million (12.1%), Ireland – USD 107.3 million (11.4%), Korea – USD 84.9 million (9.0%), and Switzerland – USD 73.9 million (7.9%).

  1. HS Code 9027 – instruments and apparatus for physical or chemical analysis (for example, polarimeters, refractometers, spectrometers, gas analyzers); instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like; instruments and apparatus for measuring or checking quantities of heat, sound or light (including exposure meters); microtomes (9.3% / USD 0.9 billion).

The major part of imports of the goods under consideration was accounted for by the Russian Federation. Its share amounted to 86.0%, or USD 793.2 million. Among the other Member States of the Union, a significant volume of supplies went to the Republic of Kazakhstan, whose share amounted to 8.1%, equivalent to USD 74.8 million in value terms. Goods worth USD 43.3 million (4.7%) were supplied to the Republic of Belarus, USD 8.5 million (0.9%) to the Republic of Armenia, and USD 2.8 million to the Kyrgyz Republic, equivalent to a share of 0.3%.

The main suppliers of goods in the commodity group under consideration to the Member States of the Union in 2021 were the United States, which supplied products worth USD 195.7 million, or 21.2% of the total volume, followed by Germany – USD 171.8 million (18.6%), China – USD 115.1 million (12.5%), Japan – USD 101.6 million (11.0%), and England – USD 43.5 million (4.7%).

  1. HS Code 9022 – apparatus based on the use of X-rays, alpha, beta or gamma radiation, whether or not for medical, surgical, dental or veterinary uses, including radiographic or radiotherapeutic apparatus, X-ray tubes and other X-ray generators, high-voltage generators, control panels and desks, screens, examination or treatment tables, chairs and similar articles (9.3% / USD 0.8 billion).

In 2021, the largest volume of goods in this group was imported into the Russian Federation, amounting to USD 673.5 million, which represented 80.5% of all imported goods in this group. Among the other Member States of the Union, a significant volume of supplies went to the Republic of Kazakhstan, whose share amounted to 11.7%, equivalent to USD 98.1 million in value terms. Goods worth USD 53.3 million (5.2%) were supplied to the Republic of Belarus, and USD 9.0 million (1.1%) and USD 2.9 million (0.3%) to the Republic of Armenia and the Kyrgyz Republic, respectively.

The main suppliers of goods in the commodity group under consideration to the Member States of the Union in 2021 were Germany, which supplied products worth USD 155.7 million, or 18.6% of the total volume, followed by the United States – USD 147.4 million (16.3%), China – USD 120.2 million (14.4%), Japan – USD 112.7 million (13.5%), and Korea – USD 71.8 million (8.6%).

  1. HS Code 9019 – mechanotherapy appliances; massage apparatus; apparatus for psychological aptitude-testing; apparatus for ozone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus (5.1% / USD 0.5 billion).

In 2021, the main volume of goods in this group was imported into the Russian Federation, amounting to USD 660.6 million, which represented 77.7% of all imported goods in this group. Among the other Member States of the Union, a significant volume of supplies went to the Republic of Kazakhstan, whose share amounted to 19.2%, equivalent to USD 163.0 million in value terms. Goods worth USD 13.8 million (1.6%) were supplied to the Republic of Belarus, USD 8.5 million (1.0%) to the Kyrgyz Republic, and USD 4.1 million to the Republic of Armenia, equivalent to a share of 0.5%.

The main suppliers of goods in the commodity group under consideration to the Member States of the Union in 2021 were China, which supplied products worth USD 210.9 million, or 46.2% of the total volume, followed by Germany – USD 77.7 million – USD 24.1 million (5.3%), and Italy – USD 17.2 million (3.8%).

At the end of 2021, the total share of imports of the five main commodity items brought into the customs territory of the Union amounted to 68.6%, which in value terms was equivalent to USD 6.2 billion. At the same time, the main suppliers were China, Germany, the United States and Japan. The structure of medical device imports is presented below in Figure I-1.

image

Figure I-1. Main imported goods of the Member States of the Union in 2021

With regard to exports of medical products manufactured in the territories of the Member States of the Union, the analysis of the trade structure by 4-digit HS codes showed that in 2021 the main commodity groups occupying leading positions were as follows:

  1. HS Code 9031 – measuring or checking instruments, appliances and machines, not specified or included elsewhere in this group; profile projectors. During the period 2018–2021, wave-like changes in the growth indicators of export operations for this commodity group were observed. The base growth indicator compared to 2018 reached 7.7% at the end of the period, while the average annual indicator stood at 2.5%. At the end of 2021, the share of these goods in the import structure amounted to 26.0%, which in value terms amounted to USD 0.3 billion.

In 2021, the Russian Federation was the main and virtually sole exporter of goods in this group among the Member States of the Union, supplying approximately 94.4% of all products sold abroad to third countries, amounting to USD 312.5 million. The Republic of Kazakhstan supplied products worth USD 5.4 million (1.6%), the Republic of Belarus – USD 12.5 million (3.8%), the Republic of Armenia – USD 0.2 million (less than 0.1%), and the Kyrgyz Republic – USD 0.3 million (0.1%).

The main destinations for supplies of goods in the commodity group under consideration from the Member States of the Union in 2021 were Algeria, which purchased products worth USD 89.2 million, or 27.0% of the total volume, followed by Egypt – USD 53.5 million (16.2%), India – USD 51.3 million (15.5%), and China – USD 16.3 million (4.9%).

  1. HS Code 9013 – liquid crystal devices, other than articles more specifically described elsewhere; lasers, other than laser diodes; other optical instruments and appliances, not specified or included elsewhere in this group (23.8% / USD 302.8 million).

The Russian Federation was the main exporter of products in this commodity group in 2021, supplying more than 86.8% of all goods sold abroad to third countries, amounting to more than USD 262.7 million. The Republic of Belarus was the second-largest exporter in terms of supply volumes, accounting for 12.8%, or USD 38.7 million. The share of exports of the other Member States of the Union for the said goods in 2021 did not exceed 0.03%.

The main consumers of goods in the commodity group under consideration from the Member States of the Union in 2021 were China, which purchased products worth USD 110.6 million, or 36.5% of the total volume, followed by Germany – USD 96.3 million (31.8%), the United States – USD 24.4 million (8.1%), India – USD 32.1 million (10.6%), and Lithuania – USD 11.6 million (3.8%).

  1. HS Code 9032 – instruments and appliances for automatic regulating or controlling (9.4% / USD 120.1 million).

The Russian Federation was the main exporter of products in this commodity group in 2021, supplying more than 94.0% of all goods sold abroad to third countries, amounting to more than USD 112.8 million. Among the other Member States of the Union, the Republic of Kazakhstan made a significant contribution to the export structure of the goods under consideration, with a share of 2.5%, equivalent to USD 3.0 million in value terms. The Republic of Belarus supplied goods worth USD 1.9 million (1.6%), and the Republic of Armenia – USD 2.2 million (1.9%).

The main destinations for supplies of the goods under consideration from the Member States of the Union in 2021 were Germany, which purchased products worth USD 24.8 million, or 20.7% of the total volume, India – USD 15.5 million, or 12.9%, and Algeria – USD 12.6 million, or 10.5%. The shares of China and Serbia, which ranked fourth and fifth, amounted to 6.9% and 6.1%, respectively.

  1. HS Code 9018 – instruments and appliances used in medical, surgical, dental or veterinary sciences, including scintigraphic apparatus, other electromedical apparatus and sight-testing instruments (8.8% / USD 111.6 million).

The main exporters of the goods under consideration in 2021 were the Russian Federation and the Republic of Belarus, which supplied goods worth USD 76.6 million and USD 29.7 million, or 68.6% and 26.6% of all export operations, respectively. The shares of the Republic of Armenia, the Republic of Kazakhstan and the Kyrgyz Republic amounted to 4.1%, 0.6% and 0.2%, respectively.

The two main export destinations of the Member States of the Union to third countries for the goods under consideration were the Netherlands and Ukraine, to which goods worth USD 26.2 million and USD 20.4 million were supplied, accounting for 23.5% and 18.3% of total exports, respectively. In addition, Uzbekistan, the United States and China were among the top five main export destinations.

  1. HS Code 9030 – oscilloscopes, spectrum analyzers and other instruments and apparatus for measuring or checking electrical quantities, other than meters of heading 9028; instruments and apparatus for detecting or measuring alpha, beta, gamma, X-ray, cosmic or other ionizing radiation (5.8% / USD 74.5 million).

In 2021, the majority of export operations involving the goods under consideration were carried out by the Russian Federation, which accounted for approximately 79.4% of the total volume of supplies, or USD 59.2 million, and the Republic of Belarus, whose share amounted to 18.0%, equivalent to USD 13.4 million in value terms. The shares of the Republic of Kazakhstan, the Kyrgyz Republic and the Republic of Armenia amounted to 1.7%, 0.8% and 0.1% of supplies, respectively.

Among the main export destinations of the Member States of the Union for goods in the group under consideration were China, which purchased more than 12.3% of all goods supplied to third countries, amounting to USD 9.2 million, and Algeria, which purchased goods worth USD 7.4 million, or 10.0%. In addition, significant purchases were made by the United States – 9.1%, India – 8.8%, and Lithuania – 8.4%.

At the end of 2021, the total share of exports of the five main commodity items supplied to third countries amounted to 73.7%, which in value terms was equivalent to USD 0.9 billion. The main export destinations of the Member States of the Union were China, the United States, India and Algeria.

The structure of medical device exports is presented in Figure I-2.

image

Figure I-2. Main exported goods of the Member States of the Union in 2021

Overall, the dynamics of foreign trade between the Member States of the Union and third countries in medical products were characterized by trends towards an increase in supplies of imported products and a reduction in export operations to foreign markets, which ultimately led to an increase in the negative trade balance. At the same time, the reduction in export operations to third countries was accompanied by an increase in the volume of mutual trade between the Member States of the Union.

It should be noted that the leading group in import operations was the group of goods under HS Code 9018 (instruments and appliances used in medical, surgical, dental or veterinary sciences, including scintigraphic apparatus, other electromedical apparatus and sight-testing instruments), which was also among the top five exported goods. At the same time, less technologically advanced products in this category dominated the export structure, whereas complex apparatus belonging to this group dominated imports.

The dependence of the markets of the Member States of the Union on imported goods used in rehabilitation and corrective treatment, relating to the field of orthopedics, is clearly evident. It is important to note that the production of modern devices in this area requires sophisticated equipment and access to a wide range of polymer products.

In addition, the markets of the Member States of the Union are significantly dependent on imports of goods included in the group under HS Code 9027 (instruments and apparatus for physical or chemical analysis (for example, polarimeters, refractometers, spectrometers, gas analyzers); instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like; instruments and apparatus for measuring or checking quantities of heat, sound or light (including exposure meters); microtomes). This is due to the almost complete absence of domestic production of certain types of goods included in this group and, consequently, a shortage of their supply on the domestic market.

Nevertheless, the statistics presented demonstrate that national manufacturers of the Member States of the Union are able to compete in foreign markets in the production of such goods as measuring or checking instruments, appliances and machines; medical lasers and optical instruments; surgical instruments and appliances; instruments and appliances for automatic regulating or controlling; as well as oscilloscopes, spectrum analyzers and other instruments and apparatus for measuring or checking electrical quantities.

2. Current state of the common market for medical devices

The functioning of the common market for medical devices within the Union is ensured by a system of acts adopted by the Union's bodies in the field of medical device circulation.

The basis for this system is the Agreement adopted pursuant to the Treaty on the Eurasian Economic Union dated May 29, 2014. The acts developed pursuant to the Agreement include decisions and recommendations of the Council and the Board of the Eurasian Economic Commission (hereinafter referred to as the Commission).

In accordance with the Agreement, uniform rules for the circulation of medical devices within the Union are established in accordance with the recommendations of the International Medical Device Regulators Forum (IMDRF). General approaches to the development of uniform rules within the Union take into account the IMDRF recommendation “Principles of Conformity Assessment for Medical Devices” (GHTF/SG1/N78:2012).

As of January 1, 2025, 21 Commission acts are in force in the field of medical device circulation, including 10 decisions of the Commission Council, 4 decisions of the Commission Board and 7 recommendations of the Commission Board, which regulate matters relating to medical device circulation assigned to the level of supranational regulation. In 2021–2024, new versions of a number of Commission decisions were adopted, taking into account their practical application and changes in certain aspects of international practice.

 Table II-1

New versions of Commission decisions

Download

 

No.

 

Name of the rules

 

New version of the rules

 
  1.  
Rules for the classification of medical devices depending on the potential risk of their useDecision No. 65 of the Commission Board dated May 23, 2023
  
  1.  
Rules for conducting technical testing of medical devicesDecision No. 25 of the Commission Council dated March 17, 2022
  
  1.  
Rules for conducting studies (tests) to assess the biological effects of medical devicesDecision No. 26 of the Commission Council dated March 17, 2022
  
  1.  
Rules for conducting clinical and clinical laboratory trials (studies) of medical devicesDecision No. 7 of the Commission Council dated January 26, 2024
  1.  
Rules for the registration and examination of the safety, quality and effectiveness of medical devicesDecision No. 144 of the Commission Council dated December 24, 2021 (as amended on March 30, 2023)

The common market for medical devices began operating on April 26, 2017, when the Protocol on the Accession of the Republic of Armenia to the Agreement was ratified by all Member States of the Union and entered into force.

In accordance with the amendments made to the transitional provisions of the Agreement (Article 11) in 2021–2023, provision has been made for the possibility of circulation of medical devices registered under the national rules of a Member State until the expiry of the validity period of the documents confirming their registration. Such medical devices may circulate only within the territory of the Member State that issued the registration.

The deadline for submitting applications for the registration of medical devices under the national rules of the Member States of the Union has been extended until the end of 2025 (Protocol dated February 13, 2023, on amendments to the Agreement). The issue of further extending the transitional period is under discussion.

The number of medical devices (by Member State of the Union) that had received registration certificates in accordance with Union law as of January 1, 2025, is presented in Figure II-3.

image

Figure II-3. Number of registration certificates issued for medical devices in each of the Member States of the Union, according to data provided by the authorized bodies of the Member States of the Union within the framework of the working group on the development of common approaches to regulating the circulation of medical devices within the Union

The introduction into Union law of inspections of the quality management system for the production of medical devices is aimed at creating an integrated approach to regulating the circulation of medical devices, ensuring the traceability of processes affecting the quality and safety of medical devices.

Currently, the system for inspecting medical device manufacturing facilities for compliance with the Requirements for the Implementation, Maintenance and Assessment of the Quality Management System for Medical Devices Depending on the Potential Risk of Their Use, approved by Decision No. 106 of the Commission Council dated November 10, 2017, has been established in the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic and the Russian Federation.

The disruption of transport and logistics connections caused by the spread of the novel coronavirus infection had a negative impact on the dynamics of the inspection process in 2020. Nevertheless, the introduction of remote inspection practices into Union law made it possible to continue work on the registration of medical devices under Union law in 2021.

The Union uses an electronic document format for submitting medical device registration dossiers.

For their transmission and circulation between the authorized bodies of the Member States of the Union through the integrated information system of the Eurasian Economic Union, 3 common processes have been implemented (2 registers and 1 information database), while another common process (information database) is technically ready and is undergoing testing. The list of common processes is provided in Table II-2.

 Table II-2

Common processes in the field of medical device circulation

Download

 

No.

 

Name

 

Status

 

Directories and classifiers

 

32

Formation, maintenance and use of the unified register of medical devices registered within the Eurasian Economic Union 

put into operation

 

10

 

33

Formation, maintenance and use of the unified register of authorized organizations entitled to conduct studies (tests) of medical devices for the purpose of their registration 

put into operation

 

5

 

34

Formation, maintenance and use of the unified information database for monitoring the safety, quality and effectiveness of medical devices 

put into operation

 

7

 

341

Exchange of information on the results of inspections of quality management systems of medical device manufacturers 

technically ready, testing is underway

 

7

3. Problematic aspects of the functioning of the common market for medical devices within the Union

An analysis of the state of the common market for medical devices within the Union and proposals submitted by the authorized bodies in the field of medical device circulation of the Member States of the Union, relevant associations (organizations), educational and scientific institutions of the Member States of the Union shows that the most problematic aspects of the functioning of the common market for medical devices within the Union currently remain:

  1. issues relating to the implementation of the common processes in the field of medical device circulation specified in Table II-2 of this Concept within the integrated information system of the Union;
  2. the need to increase the attractiveness of the market within the Union for the registration of medical devices;
  3. comparability of approaches in the preparation of expert assessments of the safety, quality and effectiveness of medical devices within the Union;
  4. the advisability of examining issues relating to the updating of interstate standards applied for the purpose of fulfilling the safety and effectiveness requirements for medical devices within the Union, in order to ensure the proper functioning of the common market for medical devices within the Union;
  5. the advisability of examining issues relating to the exchange of experience in training experts who examine registration dossier documents in various areas of expert work, including the registration of high-tech medical devices.

To address these issues, the Member States of the Union and the Commission are implementing, in addition to this Concept, an action plan (“road map”) to ensure the transition to the registration of medical devices in accordance with the Rules for the Registration and Examination of the Safety, Quality and Effectiveness of Medical Devices, approved by Order No. 36 of the Council of the Commission dated December 14, 2022.

Within the framework of the activities provided for in the said plan, proposals from individual Parties are being discussed at the Commission regarding the advisability of coordinating work on standardization in the field of medical device circulation within the Union, enabling the updating of standards that ensure compliance with the safety, quality and effectiveness requirements for medical devices established within the Union. Based on proposals submitted to the Commission by individual authorized bodies in the field of medical device circulation of the Member States of the Union, where necessary, it is proposed to consider:

identifying priority international standards on the basis of which interstate standards should be developed;

coordinating work on the development of interstate standards and amendments thereto.

In carrying out such work, Decision No. 67 of the Commission Council dated June 23, 2023, “On the Procedure for Coordinating Standardization Work within the Eurasian Economic Union”, should be taken into account with regard to organizing cooperation between standardization bodies in the development of interstate and national (state) standards related to ensuring cooperation between the Member States of the Union in the field of the medical industry.

III. STRATEGIC GOAL AND OBJECTIVES OF THE CONCEPT

The creation of the common market for medical devices in 2014–2016 envisaged the transition to uniform principles (rules) governing the operation of national structures in each Member State of the Union.

However, the economic situation that developed in 2021–2023 required the continued circulation of medical devices registered under national rules within the territories of the Member States that issued such registrations, as well as the retention of national rules for the registration of medical devices until 2026. In special cases, the possibility of introducing special provisions of national regulation in relation to medical devices is provided for.

Based on the results of law enforcement practice, it is necessary to assess the possibility of reducing the administrative burden on medical device manufacturers.

The strategic goal of this Concept is to establish a common market for medical devices that ensures conditions for equal access to medical devices within the Union. The formation of the common market for medical devices is carried out on the principles set out in Article 31 of the Treaty.

The objectives of the Concept are:

  1. Ensuring further improvement of Union law in the field of medical device circulation.
  2. Harmonizing Commission acts with the documents of the International Medical Device Regulators Forum, including in the field of medical device circulation involving artificial intelligence technologies and personalized medical devices (including those manufactured using additive technologies), as well as analyzing international experience in order to consider the possibility of introducing circular economy models in the field of medical device circulation.
  3. Further improving and optimizing digital processes in the registration and circulation of medical devices in order to simplify business processes in the Member States of the Union.

IV. MECHANISMS FOR ACHIEVING THE GOAL AND IMPLEMENTING THE OBJECTIVES OF THE CONCEPT IN VARIOUS AREAS OF THE COMMON MARKET FOR MEDICAL DEVICES

1. Improving Union law in the field of medical device circulation

Improving Union law in the field of medical device circulation through both amendments to existing Union acts and the adoption of new Union acts, including those regulating certain aspects of medical device circulation.

It should be noted that it is advisable to introduce measures that will help reduce the administrative burden on medical device manufacturers in terms of registration and examination procedures, amendments to registration dossiers and medical device testing.

Further improvement of requirements for the circulation of certain types of medical devices and the assessment of the quality management system for such medical devices:

medical devices manufactured to individual patient orders and intended for implantation into the human body;

medical devices intended for diagnosing diseases by examining human biological material samples outside the human body, manufactured in a medical organization and used in the medical organization that manufactured them, for example, reagents and kits for determining analytes for in vitro diagnostics, general laboratory reagents for in vitro diagnostics, culture media, general laboratory equipment, sample containers and general laboratory consumables; analyzers for in vitro diagnostics.

Recognition by states that are not members of the Union of the results of the assessment of the quality management system for medical device manufacturing carried out within the Union and, subsequently, of the registration of medical devices.

2. Issues relating to the circulation of medical devices involving artificial intelligence technologies and personalized medical devices (including those manufactured using additive technologies), as well as the use of circular economy models in the field of medical device circulation

The artificial intelligence market (hereinafter referred to as AI) covers a significant number of different segments. Some products and product lines are more specialized (for example, intelligent medical diagnostic services), while others can be adapted to a wide range of tasks.

Most product lines combine software, hardware and service components, which makes it possible to develop related products for various applications. Horizontal product-line segments are predominantly dominated by large digital industry companies. Markets with a more pronounced sectoral focus are characterized by lower concentration, with specialized players (companies, universities, etc.) actively participating in their development.

The introduction of AI-based products and services makes it possible to improve operational efficiency in terms of such indicators as speed (reducing the time required to complete processes, make decisions, etc.), quality (improving the consumer characteristics of products and services, enhancing customer experience, etc.), objectivity (reducing the number of errors caused by the human factor), economic efficiency (increasing revenues and reducing costs), and personalization (creating individualized offers). In the healthcare sector, this makes it possible to perform tasks such as analyzing medical images to identify pathologies, providing personalized disease prevention recommendations, documenting medical records, and providing a “second opinion” for a physician.

Regulating the circulation of software using AI technologies will make it possible to create:

platforms with datasets required for training, testing and subsequent monitoring;

mechanisms for promptly introducing changes to software product versions;

conditions for post-registration monitoring, taking into account the specific features of such medical products;

interstate standards ensuring requirements for such medical products (if necessary).

In 2021, following research work, the World Health Organization (WHO) presented the report “Ethics and Governance of Artificial Intelligence for Health” and the WHO Guidance on Ethics and Governance of Artificial Intelligence for Health (“Ethics and governance of artificial intelligence for health: WHO guidance”). The said Guidance notes that the use of AI in medicine has great potential and will contribute to more people around the world receiving proper medical care. At the same time, WHO emphasizes the risks associated with the use of AI, which can be minimized through certain ethical principles governing AI.

It is worth noting that in 2021 the Group of Seven (G7) adopted two documents on AI governance in healthcare, the ultimate goal of which is effective and safe treatment of patients:

the strategic document “Deliverable 1: Principles for the Evaluation of Artificial Intelligence or Machine Learning-Enabled Medical Devices to Assure Safety, Effectiveness and Ethicality”, which is aimed at identifying best practices for the clinical evaluation of medical devices using AI or machine learning (AI/ML);

the strategic document “Deliverable 2: Principles to Support the Development and Deployment of Artificial Intelligence or Machine Learning-Enabled Medical Devices Across Jurisdictions”, which is aimed at assessing the suitability of AI/ML-enabled medical devices developed in one G7 country for deployment in other G7 member countries.

A high-tech area in the production of modern materials is represented by additive technologies, which have a number of advantages over traditional manufacturing methods. They make it possible to reduce the time required to bring new products to market, lower machining costs, increase the material utilization rate, etc. High-tech industrial sectors, such as the production of high-tech medical devices, generate the greatest demand for additive technologies. The additive materials market is developing dynamically, and its tenfold growth is expected by 2030².

At the proposal of individual Parties, issues are being considered relating to the safety of materials used in the manufacture (printing) of medical devices, the assessment of the quality management system for the production of such medical devices, as well as issues related to the advisability of establishing approaches in Union law to the use of additive technologies in the field of medical device circulation and their standardization.

Circular economy refers to an economy characterized by a restorative and closed-loop nature, aimed at minimizing the consumption of primary raw materials and the volume of resources processed, which, in turn, is accompanied by a reduction in waste sent to landfill.

The implementation of circular economy models is provided for by the Strategic Directions for the Development of Eurasian Economic Integration until 2025 (paragraph 4.9 of the Action Plan). The following circular economy models applicable to medical devices may be identified.

 

² Based on the materials of the publication “Development of Certain High-Tech Areas. White Paper” – Moscow, 2022.

“Service Life Extension” Model

Taking into account international practice (for example, based on experience in applying the international standard IEC 63077:2019 “Good Refurbishment Practices for Medical Imaging Equipment”), it is necessary to consider the advisability and necessity of establishing specific regulations for the circulation of medical equipment that has undergone refurbishment.

“Medical Device Reprocessing” Model

The term “reprocessed medical device” refers to a single-use medical device that has undergone additional industrial processing for one more use. Taking into account international practice, it is necessary to consider the advisability and necessity of establishing specific regulations governing the circulation of this type of medical device.

  1. Further improvement and optimization of digital processes in the registration and circulation of medical devices in order to simplify business processes in the Member States of the Union

Further improvement and optimization of the information environment in the field of medical device circulation is carried out for the purpose of:

ensuring continuity in the clinical trial (study) process for medical devices, as well as ensuring their high-quality conduct and considering the possibility of creating a register of clinical studies of medical devices within the Union;

optimizing digital processes in the registration and circulation of medical devices;

transitioning the medical device registration procedure to a register-based model.

V. EXPANSION OF THE INTEGRATION OF THE UNION'S COMMON MARKET FOR MEDICAL DEVICES INTO THE INTERNATIONAL MARKET

The Commission will continue its work on harmonizing and updating Union law in the field of medical device circulation, taking into account the recommendations of the International Medical Device Regulators Forum (IMDRF).

Interaction between the Member States of the Union and the Union's observer states on harmonizing requirements for the assessment of medical devices will continue to develop, which will contribute to the recognition by the Union's partners and third countries of the results of the assessment of the quality management system for medical devices, as well as their safety and effectiveness.

Consultations on Union law in the field of medical device circulation with interested third countries are planned to be expanded.

 

Constitution Law Code Regulatory Act Decree Order Decision Resolution Lawyer Almaty Lawyer Legal Service Legal Consultation Civil Criminal Administrative Cases and Disputes Defense Arbitration Legal Company Kazakhstan Law Firm Court Cases Declaration Decree Order Resolution Decision Report Conclusion Application Conclusion Convention Contract Memorandum Methodology Rules Note Regulations Program Charter Article Commentary Resolution Regulation Protocol Project Program Rules Messages